Dose reduction cools tamoxifen’s adverse effects in cancer patients

Tamoxifen dose reduction may be possible for women experiencing severe hot flash toxicity that threatens their compliance with the drug, an Australian pilot study suggests. According to NSW research comprising a cohort of 20 women with a history of breast cancer, halving the tamoxifen dose from 20mg to 10mg reduced the women’s Loprinzi Hot Flash ...

Already a member?

Login to keep reading.

© 2019 the limbic